ST步森(002569.SZ):擬終止收購廣東信匯60.4%股權
格隆匯7月20日丨ST步森(002569.SZ)公佈,公司於2021年7月20日召開第六屆董事會第十一次會議,審議通過了《關於終止收購廣東信匯電子商務有限公司60.4%股權的議案》。該議案尚需提交公司股東大會審議。
目前收購廣東信匯股權的事項尚未完成中國人民銀行的審批程序,為保護投資者利益,易聯匯華同意退還股權收購款,公司結合自身發展階段及綜合考慮目前行業政策、市場環境等因素,決定終止上述投資。
公吿顯示,該次交易事項的終止,不會對公司經營及現有業務的發展產生重大不利影響。易聯匯華同意退還股權收購款,承諾近期分批將前期支付的股權收購款退還公司。截至目前公司已收到其退回的4000萬元股權款。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.